Recent

% | $
Quotes you view appear here for quick access.

IntelGenx Technologies Corp. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    "Day after day week after week month after month and year after year you spew the same BS"

    Congratulations - You described yourself perfectly with the beginning of your post.

    Sentiment: Strong Buy

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Day after day week after week month after month and year after year you spew the same BS and nothing EVER happens you say it is! We don't have one single thing going for us compared to 3 years ago! We have no other drugs approved, no other revenue streams, no other partners, nothing zip zilch. All you and others have done in that time frame have spoke your pipe dreams and wait until blah blah blah, or wow horse has done amazing things BS and the truth is he has not. So continue to ramble on and bash people that speak the truth backed by facts whilst you sit and give your "opinion" of all this amazing #$%$ happening "just wait n see" attitude garbage! Maaaaan I can't believe we let those term sheets slip through our fingers, but it's a good thing because Horseazz is waiting for a super deal! The price is in the dumps because of a forced sale from a fund closing or maybe hype up the empty factory some more

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    I have been is this for the last 31/2 years. Based on the BS your mentioned we should be in the mid-teen and in the .50's. Know what your saying not what your hoping. Let's just HOPE financially we can still support the PPS and not RS the dam things again.

    Sentiment: Hold

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    "I have stated many times over the past".....

    glucom, seriously, do you ever get tired and/or bored hearing yourself talk/opine/post/speak?

    Wow you are a blow-hard old man.

    EnteroMedics ran from $969 to an astonishing .51 cents and
    absolutely "nobody" pushed harder carnival barking the great
    paradigm shifting modern weight loss miracle the revolutionary
    Maestro vBloc device that will change the way the world deals with obesity and how ALL OF US WILL BE MILLIONAIRES buying in on this true ONCE-IN-A-LIFETIME opportunity.

    You are a fickle boring little old man who has one best friend
    in himself....

    fwiw

    ~

    .

    Sentiment: Strong Buy

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    "a way of getting more money from investors to support executive salaries"....

    I understand completely we are all entitled to our individual opinions, but
    my gosh man, you are a complete obtuse stupid fool.....

    This company produces successful products, brings-in/produces +5M a year
    in revenues and the brass earns moderate/frugal compensation.

    For a company that fits your sentiment please see EnteroMedics or any one of
    the thousands of non revenue, non sales producing publicly traded equities in the
    market place.

    You have a very weak intellect.

    You, ragbull and a few other mental light weights with obviously little cash
    and/or resources in life need to get-over Horst and Ingrids multi million dollar
    rights and soon to be +50 or 100 million holdings in this company. Get over it.

    Whatawhinyvindictivepussy you are.....

    Hope this helps!

    ~

    Sentiment: Strong Buy

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Those two deals have been in the works long before new management were brought in and it is at least $5.25 in milestones on Forfivo if not more.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    "having manufacturing capability and a broader management team has lead to a much higher level and intensity to their deal-making capability from what I have heard."
    I'm sorry, but that's been said year over year and is pumper language. We need results. Not another maybe in the future things will get better. IGXT has had time enough to deliver and they failed. Time is running out, they need to focus and stay away from this new wannabe business. Simple task: deliver Suboxone, Rizaport and ED within 1-1.5 years and stick to the plan. Maybe, just maybe we shareholders will benefit. But if they keep chasing dreams..... I'm not so sure. We'll see.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    "having manufacturing capability and a broader management team has lead to a much higher level and intensity to their deal-making capability from what I have heard."
    That I agree on ad have stated many times over the last year or more as prior deals didn't turn out. The Dava and Par deals are several years old and when Dava was bought out they returned the drug as Par did 2 out of 3. The new deals are very important and with the expanded management guys in only a couple of months got two deals going in that time. Hopefully we will see several more n the coming months. There is the rest of the EU for migraine, Migraine in the U.S.,Cialis worldwide and several others in the pipeline that need to move forward and will faster with development/commercialization partners.
    As far as 450 I believe they did get a $1M on the extension of the agreement, but that is only $5M in milestones since Dec. 2012 and they haven't made that much in royalty revenue less costs since 10/2012 when it was approved (4 years ago).
    The positive is it looks like they are now moving the pipeline along at a much faster and with the new management and new development partners shouldn't see anymore CRL's. Its the new guys and partners that will make this company valuable. Horst has done all he can do business wise. He wants to and needs to retire and only consult from the board. Kudos to him for getting the company in the position it is in now to add value and stop the stagnation and inefficiencies (CRL's).

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    The new deals are important. However, having manufacturing capability and a broader management team has lead to a much higher level and intensity to their deal-making capability from what I have heard. Also, there was a deal with Dava that was given back as well if my memory serves as a result of them being acquired and that drug is also available for partnering. Also, the Forfivo deal was more lucrative than you are giving it credit for. There were exclusivity milestone payments they received as well that you are leaving out.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Patrick that is why these two new deals are so important to complete as the only development/commercialization deal they have completed was the Par deal for 3 drugs and 2 were given back, which should be good news because now they can get a better deal than the one with Par. 450 was just a commercialization deal and that is not a great deal for IGXT even though it is doing well. Out of the $23M in milestones they have only received $4M to date.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    I disagree completely. They have several generics that will generate tons of cash flow in the near-term and take on bigger/risk reward situations for the longer-term when they can afford to. They will take on partners at the opportune time so that they can gain the most value and have someone else pay for the development/legal costs like they always have.

  • Reply to

    Cialis question

    by tasso9 May 25, 2016 12:05 AM

    Your question would be something IntelGenx could only dream about. If that would happen there is no limit on the PPS, we could see something in the teen or more. MHO

    Sentiment: Hold

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Tells me they've given up on some of their other ventures because of delays or other concerns or just a way of getting more money from investors to support excutive salaries. MHO

    Sentiment: Hold

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    There is some validity to what you say, but Horst has been fairly frugal in the past other than the issuance of now 74M shares, none sense 21/2 years ago. Hopefully the development agreements bringing in upfront payments for now is his strategy to cover the short fall in the cash flow, along with lowering IGXT's R&D expenses by passing them on to the new partners. Upfront payments and lower R&D costs will also add to ForFivo income to hopefully offset any losses until new revenues come in in mid to late 2017.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Well the good news is we will never know since this company goes months and years with no news release and not telling us anything! How do you have 3 news releases a year all of which are fluff and go years on end with nothing?

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    Just rushing into dementia-market is really unrealistic. There's big boys there throwing billions of USD on r&d. really: igxt is not going to be the David vs Goliath and having their Eureka-moment in finding out that asperine is the solution to dementia. We are far past that kind of "research". IGXT is a very small bio which had a good business-niche: planting old drugs on a film that could bring proven drugs faster in your system, suitable for people having trouble taking pills. Why is it so difficult to just do that.

  • Reply to

    Repurposing vs generics on film

    by igxteurope May 25, 2016 3:45 AM

    I agree with everything you said! He pushes this company like a pump and dump in the aspect of something new and exciting just around the corner and nothing actually comes to fruition! We have one drug in 4 years! You cannot compete with the generic beast working that slow. Don't get me wrong the dementia market would be massive but we can't even fix a migraine I seriously doubt we are going to be rejuvenating old brains and fixing dying neurological synapses and deficits any time soon! Where did those term sheets go anyways?

  • Where did the board made this move from focussing on re-using generics on a new delivery platform towards repurposing drugs? It is a completely other business, which will take much more time to get old drugs approved on other use, then it takes to use old drugs simply putting them on another platform (film) in use for the same treatment. I don't see a clear businessmodel, strategic thoughts on this move.
    IMO this is one of the big problems Zerbe created: jumping from one thing (unfinished) into the next, without making clear to shareholders of why this is happening. I could have imagined if they had Riza, Suboxone and maybe ED deliverd on their films, approved and marketed, they could take a broather view on productdeveloping. But I'm in the dark of this path. Seems to me they either don't know what they are doing, or they know they are way to slow in the generic market to ever make big profits on that. Still: they will need a lot of money and partnering up, time and research if they really want to repurpose drugs on other use.
    IMO: stick to the plan, speed up and start to deliver generics on Versafilm really fast!

  • Would Eli Lilly cut a deal with intelgenx and work together, abandon their pill format, work with our film format, and reach a percentage cut on sales.

  • Reply to

    Dimentia

    by tasso9 May 24, 2016 5:53 PM

    Would be nice to get more pharma on reperpessing their drugs with our film delivery system and some good cut on the action ( upfront payments and royalties).

Must Watch
IGXT
0.54-0.01(-1.82%)May 25 12:29 PMEDT